Mesenchymal Stem Cells Modulate Immune Response and Promote Angiogenesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for autoimmune diseases, graft-versus-host disease, inflammation, epithelial damage, cancer, allergic responses, and wound healing are inadequate in effectively modulating immune responses and promoting tissue repair.
Innovation Solution
Administration of mesenchymal stem cells (MSCs) to regulate immune responses by promoting the release of anti-inflammatory cytokines, inhibiting pro-inflammatory cytokines, and stimulating angiogenesis, thereby treating a wide range of diseases and disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for autoimmune diseases and inflammation, then current standard therapies are applied, but effective modulation of immune responses and promotion of tissue repair is insufficient
Solution Approach 1:
The patent introduces mesenchymal stem cells as intermediary cells that mediate between the immune system and damaged tissue. These MSCs secretely express anti-inflammatory cytokines (IL-10, TGF-β) and growth factors (VEGF, PDGF) to simultaneously modulate immune responses and promote tissue repair, resolving the contradiction between effective immune modulation and tissue regeneration promotion
Solution Approach 2:
The patent demonstrates that mesenchymal stem cells perform multiple functions simultaneously: they suppress pro-inflammatory cytokines (TNF-α, IL-1β), promote anti-inflammatory cytokines (IL-10, TGF-β), and stimulate angiogenesis through VEGF and PDGF expression. This multi-functionality allows a single cell type to address both immune modulation and tissue repair requirements
2Adaptability or versatility
If mesenchymal stem cells are administered to treat multiple diseases, then broad therapeutic coverage is achieved, but the complexity of treating diverse conditions increases
Solution Approach 1:
The patent establishes that mesenchymal stem cells serve as a universal therapeutic platform capable of treating diverse conditions including autoimmune diseases (MS, RA, IBD), graft-versus-host disease, cancer, allergic responses, and wound healing. The same cell type with its inherent multi-functionality (immune modulation + tissue repair) provides broad therapeutic coverage without requiring disease-specific different treatments
Solution Approach 2:
The patent indicates that the therapeutic effects of mesenchymal stem cells can be optimized by controlling parameters such as cell dosage (1×10⁶ to 1×10⁸ cells/kg body weight), administration route (intravenous, intra-articular, intraspinal), and cell source (bone marrow, umbilical cord, adipose tissue). These parameter adjustments allow adaptation to different disease severities and types without changing the fundamental treatment approach
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
MSCs effectively treat autoimmune diseases, graft-versus-host disease, inflammation, cancer, allergic responses, and promote wound healing by modulating immune responses and stimulating angiogenesis, leading to significant clinical improvements.
Implementation Method 1
regulating the production of various factors that may regulate several steps in the immune response process
Implementation Method 2
inhibiting pro-inflammatory cytokines
Implementation Method 3
promoting angiogenesis in various tissues and organs
Data Source
AI summary
Compositions and methods of promoting wound healing in a human by administering to the human mesenchymal stem cells in an effective amount.